Comparative Analysis of Long COVID and Post-Vaccination Syndrome: A Cross-Sectional Study of Clinical Symptoms and Machine Learning-Based Differentiation
Krumholz, H. M.; Sawano, M.; Wu, Y.; Shah, R.; Zhou, T.; Arun, A. S.; Khosla, P.; Kaleem, S.; Vashist, A.; Bhattacharjee, B.; Lu, Y.; Warner, F.; Huang, C.; Guan, L.; Caraballo, C.; Putrino, D.; Hertz, D.; Dressen, B.; Michelsen, T.; Fisher, L.; Adinig, C.; Bishop, P.; Iwasaki, A.
Show abstract
ImportanceLong COVID is a well-documented post-viral syndrome, while post-vaccination syndrome (PVS) remains poorly characterized. Understanding their similarities and differences is essential for refining diagnostic criteria and developing targeted interventions. This study systematically compares the symptomatology of long COVID and PVS following COVID-19 vaccination, highlighting key distinctions that could inform clinical practice and research. ObjectiveTo assess the clinical characteristics of long COVID and PVS and identify key distinguishing features between the conditions. Design, Setting and ParticipantsThis cross-sectional analysis used questionnaire data from the decentralized Yale Listen to Immune, Symptom and Treatment Experiences Now (LISTEN) Study, collected from May 2022 to July 2023. Data analysis occurred between July 2023 and May 2024. A convenience sample of adults (age [≥]18 years) with either long COVID or PVS was included. Main Outcomes and MeasuresSymptom data were analyzed using clustering techniques to identify groups with shared symptom patterns. A gradient-boosted machine learning model was used to determine the most distinguishing symptoms between long COVID and PVS. ResultsThe long COVID group (n = 441) and PVS group (n = 241) had similar demographic profiles (median age 46 years; 74% vs 80% female, respectively). Participants with long COVID most commonly reported brain fog, altered sense of smell and taste, shortness of breath, fatigue, memory problems, and difficulty speaking. Participants with PVS more frequently reported burning sensations, neuropathy, and numbness. Clustering analysis identified three symptom-based subgroups: one enriched for neurological symptoms and PVS; one characterized by multi-system symptoms and predominantly long COVID; and one dominated by psychiatric and sleep symptoms, also primarily long COVID. The machine learning model achieved an AUC of 0.79 (95% CI, 0.75-0.82) and highlighted altered sense of smell, cough, burning sensations, and brain fog as key differentiators. Conclusions and RelevanceAlthough long COVID and PVS share overlapping symptoms, they have distinct clinical profiles, suggesting the possibility of different underlying biological mechanisms. These distinctions may help refine diagnostic criteria, guide personalized treatment strategies, and inform further research into their respective pathophysiology. KEY POINTSO_ST_ABSQuestionC_ST_ABSWhat are the similarities and differences between long COVID and post-vaccination syndrome (PVS)? FindingsIn this cross-sectional study of 682 individuals, machine learning models identified distinct symptoms between long COVID and PVS. Long COVID was characterized by brain fog, altered sense of smell, and shortness of breath, while PVS was associated with burning sensations, neuropathy, and numbness. MeaningAlthough long COVID and PVS share overlapping symptoms, they have distinctive symptom profiles, suggesting potentially different underlying biological mechanisms. Understanding these differences can guide clinical diagnosis and targeted management, and inform further research into their distinct immune and biological pathways.
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact 96%
- Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge 91%
- Serious hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants: an exposed-unexposed cohort study in December 2021 from the COVID-19 surveillance databases in France 91%
Similar papers in this journal
- Factors Associated with Long Covid Symptoms in an Online Cohort Study 96%
- Post-acute sequelae of SARS-CoV-2 (PASC) impact quality of life at 6, 12 and 18 months post-infection 94%
- High proportion of post-acute sequelae of SARS-CoV-2 infection in individuals 1-6 months after illness and association with disease severity in an outpatient telemedicine population 94%
Similar papers in this journal
- Genetic Risk Factors for Severe and Fatigue Dominant Long COVID and Commonalities with ME/CFS Identified by Combinatorial Analysis 91%
- Gut microbiome dysbiosis and immune activation correlate with somatic and neuropsychiatric symptoms in COVID-19 patients 90%
- Genetic Risk Factors for ME/CFS Identified using Combinatorial Analysis 88%
Similar papers in this journal
- Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial 93%
- Self-reported Memory Problems Eight Months after Non-Hospitalized COVID-19 in a Large Cohort 91%
- Estimating the Burden of Influenza on Daily Activity at Population Scale Using Commercial Wearable Sensors 91%
Similar papers in this journal
- Refinement of post-COVID condition core symptoms, subtypes, determinants, and health impacts: A cohort study integrating real-world data and patient-reported outcomes 95%
- Characterizing Long COVID: Deep Phenotype of a Complex Condition 94%
- Role of human challenge trials (HCTs) in drug development for respiratory syncytial virus (RSV) 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.